ActoBio

Rebranding

Challenge

Intrexon ActoBiotics, a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON), decided to create a new brand to communicate their scientific breakthroughs. We were asked to develop a new brand identity and support them in all communications.

Projects

Various hard copy and digital communication assets including new website, corporate presentations, custom disease icons, full rebranding (concept, logo, brand promise, tagline).

 

About the Client

ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics® for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis. For more information, visit www.actobio.com

 

Let us inspire your new brand identity!

CONTACT US

Share
Next MyCartis